StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SHANTIDENM.BO$47.00-1.88%
Fair $47.00+0.0%

SHANTIDENM.BO

Shanti Spintex Limited

Consumer Cyclical / Textile ManufacturingBSE

$47.00

-0.90 (-1.88%)

Fairly Valued+0.0%Fair Value $47.00Fund rank 30/100 · Data gapFallback financials|
SA 48/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 23%

FCF escenarios

weak_data · normalized FCF $22.9M · quality 57.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 34/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SHANTIDENM.BOLocal privado en este navegador · Shanti Spintex Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$794M

P/E

7.4x

↓

EV/EBITDA

4.2x

↓

ROE

10.5%

↑

Gross Margin

3.3%

↓

Debt/Equity

0.14

↓
52-Week Range$47
$42$79

TradingView lightweight chart

SHANTIDENM.BO price, volumen y niveles de valoración

Último $47.00Periodo -30.6%
Fair value: $47.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+40.7%

FCF CAGR

+49.1%

FCF margin

2.3%

FCF / Net income

1.62x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.10B · net income $102.0M · FCF $165.5M

2022-FY → 2025-FY

Gross margin

3.3%-2.8% pts

Operating margin

2.1%-1.2% pts

Net margin

1.4%-0.5% pts

FCF margin

2.3%+0.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$7.10B$7.10B$5.06B$3.70B$2.55B
Net Income$102.0M$102.0M$130.2M$101.3M$48.7M
EBITDA$202.0M$202.0M$258.9M$220.2M$122.3M
EPS6.046.048.716.002.88
Gross Margin3.3%3.3%5.6%6.8%6.1%
Operating Margin2.1%2.1%3.9%4.7%3.3%
Net Margin1.4%1.4%2.6%2.7%1.9%
Balance Sheet
Debt/Equity0.140.140.260.741.05
Current Ratio1.471.47———
Cash Flow
Free Cash Flow$165.5M$165.5M$-9.8M$22.9M$49.9M
Returns
ROE10.5%10.5%15.0%18.1%10.5%
Valuation
P/E7.447.44———
EV/EBITDA4.214.21———
P/B0.820.82———
Growth & Yield
Revenue Growth40.4%40.4%36.6%45.3%—
EPS Growth-30.7%-30.7%45.2%108.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-11.6%

fácil

EPS terminal req.

$4.17

Spread vs growth

-19.0%

5Y implied EPS CAGR

-3.5%

fácil

EPS terminal req.

$5.05

Spread vs growth

-27.1%

10Y implied EPS CAGR

3.0%

fácil

EPS terminal req.

$8.13

Spread vs growth

-33.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -19.0%

Total return

-19.0%

Start / end P/E

6.7x → 7.8x

EPS bridge

8.71 → 6.04

Residual

-5.1%

EPS growth-30.7%
Multiple rerating+16.8%
Dividend+0.0%
Residual / FX / buybacks / cross-term-5.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.